COMMUNIQUÉS West-GlobeNewswire

-
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
22/08/2025 -
Human Appeal launches emergency appeal to deliver 12,000 hot meals in Pakistan
22/08/2025 -
Des pas en alimentation durable… mais trop petits pour bien nourrir tout le Québec
22/08/2025 -
Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions
22/08/2025 -
Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware
22/08/2025 -
Highsman and Illicit Partner to Bring HIT STICKS to Missouri with Exclusive Launch Weekend
22/08/2025 -
CrazyBulk Supplements Bulking Stacks 2025: Crazy Bulk Launch “Safest Legal Steroid Alternatives” for Muscle Growth & Strength for Over 50's
22/08/2025 -
NMDP Named ‘Best Place to Work’ Fifth Year in a Row
22/08/2025 -
Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing
22/08/2025 -
Trading by management and close relations of management
22/08/2025 -
Legendary Swiss Brand BILATTE Ushers In Home Medical Beauty Care 3.0 Era
22/08/2025 -
Simple Consult Launches $29 Insurance-Free Online Medical Consultations
22/08/2025 -
Trading by management and close relations of management
22/08/2025 -
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors
22/08/2025 -
Repligen Corporation to Present at Upcoming September Conferences
22/08/2025 -
BlossomHill Therapeutics Announces First Patient Dosed in Expansion Cohorts of the Phase 1/2 SOLARA Trial, Evaluating BH-30643 in Advanced EGFR-mutant Non-Small Cell Lung Cancer
22/08/2025 -
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
22/08/2025 -
Flaggemelding
22/08/2025 -
Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)
22/08/2025
Pages